NeoGenomics (NASDAQ:NEO) shares plunged on Tuesday after the cancer lab operator reported lower-than-expected revenue for Q1 ...

Q1 2025 Earnings Call Transcript April 29, 2025 NeoGenomics, Inc. misses on earnings expectations. Reported EPS is $-0.20352 ...

Shares of oncology (cancer) diagnostics company NeoGenomics (NASDAQ:NEO) fell 34.8% in the afternoon session after the ...

Oncology (cancer) diagnostics company NeoGenomics (NASDAQ:NEO) fell short of the market’s revenue expectations in Q1 CY2025, ...

NeoGenomics shares dropped 34% on April 29 after missing its Q1 revenue estimates. Check out why I view the stock price ...

NeoGenomics (NEO) reported break-even quarterly earnings per share versus the Zacks Consensus Estimate of a loss of $0.02. This compares to loss of $0.02 per share a year ago. These figures are ...

The firm increased its portfolio allocation in NEO by 11.85% over the last quarter ... the author and do not necessarily reflect those of Nasdaq, Inc. Fintel is a leading provider of financial ...

Oncology (cancer) diagnostics company NeoGenomics (NASDAQ:NEO) will be reporting earnings tomorrow morning. Here’s what ...

Shares of oncology (cancer) diagnostics company NeoGenomics (NASDAQ:NEO) fell 34.8% in the afternoon session after the company reported disappointing first-quarter 2025 earnings as sales fell ...